Tag: Androgen deprivation therapy

The American Cancer Society estimates there will be about 313,780 new cases of prostate cancer in the United States in 2025 [1.6.2]. A primary treatment involves asking: **Can Zoladex and Casodex be taken together?** Yes, this combination is a standard approach.

Approximately 1 in 8 men will be diagnosed with prostate cancer during his lifetime. For those with advanced, hormone-dependent disease, an effective treatment option is a **Camcevi injection**, an advanced androgen deprivation therapy (ADT).

Originally approved by the FDA in 1995 for treating prostate cancer, bicalutamide is a hormonal therapy medication that blocks the effects of male hormones. This non-steroidal antiandrogen is a key component of cancer treatment strategies to stop the growth and spread of hormone-sensitive cancer cells. This article explores the primary uses, mechanism, and essential details regarding **what is bicalutamide used for**.

According to the National Cancer Institute, Eligard is a type of hormone therapy known as a gonadotropin-releasing hormone (GnRH) agonist. It is primarily used to manage advanced prostate cancer by suppressing testosterone levels in the body.

First approved by the FDA in 1989, flutamide was the first nonsteroidal antiandrogen on the market, offering a new approach to hormone therapy. As a potent inhibitor of male hormones, understanding what is flutamide used for involves exploring its primary role in cancer treatment, as well as its historical application for androgen-dependent conditions in women.